GGT5 and bladder transitional cell carcinoma: The findings revealed a positive relationship between elevated GGT5 expression and immune checkpoint-related genes in most cancer types, particularly in STAD, excluding thymoma (THYM), PCPG, acute myeloid leukemia (LAML), KICH, and bladder urothelial carcinoma (BLCA) (Fig. 3A).